Patent ID: 9060540
Filing Date: 2015-06-23
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for increasing IgA secretion in an infant delivered by caesarean section during the first four months of the life of the infant comprising administering to the infant a composition comprising a probiotic bacteria, a protein source, and an oligosaccharide mixture, the composition is administered to the infant in a therapeutically-effective amount to promote colonization of microorganism species other than the probiotic bacteria that is administered, the composition comprises the probiotic bacteria in an amount between 10 7 and 10 12 cfu/g, the probiotic bacteria comprises a strain selected from the group consisting of Lactobacillus rhamnosus ATCC 53103, Lactobacillus rhamnosus CGMCC 1.3724, Lactobacillus reuteri ATCC 55730, Lactobacillus reuteri DSM 17938, Lactobacillus fermentum VRI 003 (NM02/31074), Lactobacillus paracasei CNCM I-2116, Bifidobacterium lactis CNCM I-3446 , Bifidobacterium longum ATCC BAA-999, and Bifidobacterium breve Bb-03, the protein source comprising at least 50% whey by weight of the protein source, the protein source is present in the composition in an amount of not more than 2.0 g/100 kcal of the composition, and the oligosaccharide mixture comprising galacto-oligosaccharides, N-acetylated oligosaccharides and sialylated oligosaccharides in which the N-acetylated oligosaccharides are 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharides are 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharides are 1.0 to 4.0% of the oligosaccharide mixture by weight.